Ligand validation:6ZO5

LMT: DODECYL-BETA-D-MALTOSIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZO5_LMT_C_1106	38%	74%	0.206	0.909	0.46	0.56	-	-	0	0	100%	1
6ZO5_LMT_B_1104	26%	72%	0.216	0.858	0.43	0.64	-	-	0	0	100%	1
6ZO5_LMT_A_1103	24%	70%	0.208	0.834	0.45	0.71	-	1	0	0	100%	1
6ZO5_LMT_B_1103	19%	73%	0.254	0.846	0.46	0.57	-	-	0	0	100%	1
6ZO5_LMT_A_1105	18%	74%	0.283	0.871	0.44	0.56	-	-	0	0	100%	1
6ZO5_LMT_A_1104	8%	63%	0.307	0.775	0.47	0.92	-	2	0	0	100%	1
6ZO5_LMT_A_1102	6%	69%	0.276	0.712	0.44	0.74	-	-	0	0	100%	1
6ZO5_LMT_B_1105	2%	67%	0.337	0.634	0.47	0.78	-	1	0	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1
4U95_LMT_C_1101	69%	65%	0.121	0.935	0.43	0.9	-	2	2	0	100%	1
4DX5_LMT_C_1102	69%	42%	0.124	0.937	1.18	1.09	3	2	1	0	100%	1
4DX7_LMT_A_1101	69%	36%	0.131	0.944	1.24	1.26	4	6	3	0	100%	1
4U96_LMT_C_1101	64%	65%	0.137	0.937	0.44	0.9	-	1	0	0	100%	1
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
3CAY_LMT_A_512	94%	59%	0.071	0.968	0.66	0.9	-	1	0	0	100%	1
3SZF_LMT_A_501	73%	33%	0.101	0.928	1.23	1.44	3	5	2	0	100%	1
3T14_LMT_A_501	72%	31%	0.12	0.945	1.21	1.54	3	10	2	0	100%	1
5WS6_LMT_M_101	71%	58%	0.098	0.919	0.5	1.08	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.